Summary: An economical enzymatic assay for HDL phosphatidyl choline is described, äs adapted for the Cobas-Bio analyser (Hoffmann LaRoche). This method entails the enzymatic cleavage of phosphatidyl choline by phospholipase C from B.cereus, hydrolysis of phosphoryl choline and enzymatic determination of choline with choline oxidase by an enzymatic colour test. This method provides consistent values and is, by comparison to the enzymatic UV method (assaying choline with choline kinase in an optical test procedure), simpler to perform, more precise, and less expensive.
Introduction
It has been shown in epidemiological (1) (2) (3) (4) (5) and clinical (6, 7) studies that HDL cholesterpl represents a risk indicator for cpronary heart disease. HDL, however, do not constitute a single substance, but comprise a heterogeiieous mixture of macromölecules of various composition, metabolism, and physicochemieal properties. Only after the additional determination of other HDL components, such äs HDL apolipoproteins or HDL phospholipids, is it possible to gain any Information regarding HDL composition or HDL mass. This group recently reported pn an enzymatic method for determining HDL phosphatidyl choline (8) . The principle of the method involves the specific cleavage Pf phosphatidyl choline by phospholipase C from B.cereus, followed by enzymatic determination of choline hydrolysed from phosphorylcholine by choline kinase, äs detected by an optical method. Although the newly proposed enzymatic method is less laborious and more precise than the previously employed conventional chemical method, it involves various disadvantages including relatively high cost of analysis, relatively low processing rate (20-30 samples/day in duplicate) and poor automation eapability. In the following we report a modification of the enzymatic HDL phosphatidyl choline assay, which we have adapted for use with the Cobas-Bio centrifugal analyser (Hoffmann LaRoche). 
Materials and Methode

Sample material
We used samples of the serum collected for the 'Prospective epidemiological study of Company employees in Westfalia* reported elsewhere (8) .
Methods
HOL Isolation
HDL was isolated by ultracentrifugation or by precipitation of apolipoprotein B-containing lipoproteins with phosphotungstic acid/MgCh, s described in detail elsewhere (9) .
Enzymattc determination of HDL phosphatidyl choline
Choline kinase method: This method is described in detail elsewhere (8) . The reagent Solutions were freshly prepared in the following manner: reaction solution A -10 ml monotest cholesterol -500 μΐ phosphoHpase C (90 kU/1) -50 μΐ alkaline phosphatase (1400 kU/1)
Start reagent B -100 μΐ choline oxidase (50 kU/1) -500 μΐ NaOsolution (0.15 moi/1) • r 3 μΐ sample were mixed with 300 ul solution A and incubated at 37 °C for 15 minutes. The absorbance of this mixture at 500 nm was recorded. Exactly 7.0 minutes after addition of 10 μΐ of the Start reagent B, absorbance at 500 nm was recorded againj keeping the temperature at 37 °C. Calculation was made ori.the basis of the difference in absorbance ΔΑ with respect to a choline Standard. The cohcentration of the choline Standard was determined gravimetrically and by means of the choline kinase method (8) . 
Results
Course of reaction
The choline oxidase activity in the test solution was chosen so that the i dieatoi reaction (formation of 4-(p-benzoquinonemonoamino)-phen 2one) did not run to eornpletion within the ineubation period. Und er the given conditions the increase in extinetion time was constant over the measurement period, which was selected at 7.0 minutes.
Linearity
In order to determine the linearity, a solution of lyophilised control serum was made with one-fourth the original w ter Content, a dilution series was made, and phosphatidyl choline Content was determined in the samples prepared. The measured values were proportional to the sample dilution within the r nge tested (0.17 mmol/1-2.73 mmol/1) ( fig. 1 ).
Accuracy
Comparison of the HDL phosphatidyl choline values obtained with the choline oxidase and choline kinase methods showed good correspondence of results (r = 0.9779, y = 0.9396x + 0.0577, n = 32).
Regression analysis of the data of the apolipoprotein B-free superiiatant s well s of the d > 1.063 kg/l fraction isolated by ultracentrifugation also indicated that the phosphatidyl choline values obtained with the choline oxidase method from the apolipoprotein B-free supernatant corresponded weil with the phosphatidyl choline values for HDL fractions isolated by ultracentrifugation (r = 0.97, y = 0.89x -h 0.12, n = 90) ( fig. 2) .
Precision
Precision of the series was represented by a coefficient of Variation of 2.8% (x = 0.993 mniol/1, n = 10). Day-to-day precision was determined with ser um samples taken from a fresh serum pool and stored in aliquots at -20 °C. The coefficient of Variation for day-to-day precision was 5.49% (x = 1.012 mrnol/1, n = 19).
Discussion
Routine assay of phospholipids without undue effort has been possible since the advent of commercially available phospholipases with specific cleavage properties. The phosphatidyl choline assay recently described by us (8) entails the specific cleavage of phosphatidyl choline into diglycerides and phosphorylcholine by phospholipase C, hydrolytic cleavage of phpsphorylcholine with alkaline phosphatase, followed by enzymatic determination of choline with choline kinase, using an optical test (UV method).
Substantial drawbacks to the UV method are, however, the high cost of analysis^ relatively low processing rate (approx. 20-30 samples/day in duplicate), and difficulties associated with automation of the method.
The improved method described here is distinguished from the UV method by the change in indicator reaction, in which choline is converted by choline oxidase in an enzymatic colour test. In Order to conserve choline oxidase, the reaction may be recorded with fixed-time kinetics. Prerequisites are linearity of the reaction within the measuring period and complete cleavage of phosphatidyl choline during the pre-incubation period, which we established by thin-layer chromatography of the lipid extract subsequent to phospholipase C and alkaline phosphatase action. We used an aquepus choline Standard s a reference. We believe the use of micellar phosphatidyl choline is problematic, since phosphatidyl choline is then present in a physicochemical form completely different from that in native serum, the apolipoprotein B-free supernatant, or the HDL fraction isolated by ultracentrifugation.
The assay of phosphatidyl choline in the apolipoprotein B-free supernatant (HDL phosphatidyl choline) was adapted by us for use with the Cobas-Bio centrifugal analyser. This is a simplification which provides for a significant improvement in precision of the method and a reduction in reagent costs. Use of the commercial cholesterol monotest renders superfluous the preparation of reagents for the choline assay, but further reduction in reagent costs may be achieved by mixing one's own reagents. The phosphatidyl choline assay started by choline oxidase is not influenced by the reagent for cholesterol determination, since the colour reaction for all of the cholesterol is complete by the end of the preincubation period. The data obtained with the enzymatic colour test on the Cobas-Bio analyser correlates well with the HDL phosphatidyl choline values obtained man-ually with the UV method. In view of the close correlation of the values from the UV method with those obtained by the conventional chemical method (8) , the present study does not include a comparison between data from the enzymatic colour test and the chemical method. The results of this study also indicate a close correlation of phosphatidyl choline values between the apolipoprotein B-free supernatant and the d > 1.063 kg/l fraction isolated by ult racentrifugation.
